These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7902615

  • 1. Dopamine receptors labelled by PHNO.
    Seeman P, Ulpian C, Larsen RD, Anderson PS.
    Synapse; 1993 Aug; 14(4):254-62. PubMed ID: 7902615
    [Abstract] [Full Text] [Related]

  • 2. Dopamine D2 receptors mapped in rat brain with [3H](+)PHNO.
    Nobrega JN, Seeman P.
    Synapse; 1994 Jul; 17(3):167-72. PubMed ID: 7974199
    [Abstract] [Full Text] [Related]

  • 3. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
    Seeman P, Ko F, Willeit M, McCormick P, Ginovart N.
    Synapse; 2005 Nov; 58(2):122-8. PubMed ID: 16088951
    [Abstract] [Full Text] [Related]

  • 4. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L, Wilson AA, Garcia A, Houle S, Kapur S, Ginovart N.
    Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
    [Abstract] [Full Text] [Related]

  • 5. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Peng T, Zysk J, Dorff P, Elmore CS, Ström P, Malmquist J, Ding M, Tuke D, Werkheiser J, Widzowski D, Mrzljak L, Maier D.
    Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
    Kiss B, Horti F, Bobok A.
    Synapse; 2011 Jun; 65(6):467-78. PubMed ID: 20936685
    [Abstract] [Full Text] [Related]

  • 7. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
    McCormick PN, Kapur S, Seeman P, Wilson AA.
    Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
    [Abstract] [Full Text] [Related]

  • 8. Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans.
    Seeman P.
    Synapse; 2012 Jan; 66(1):88-93. PubMed ID: 21954082
    [Abstract] [Full Text] [Related]

  • 9. Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2(High) receptors and marked supersensitivity to the dopamine agonist (+)PHNO.
    Seeman P, Battaglia G, Corti C, Corsi M, Bruno V.
    Synapse; 2009 Mar; 63(3):247-51. PubMed ID: 19084908
    [Abstract] [Full Text] [Related]

  • 10. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE, Creese I.
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [Abstract] [Full Text] [Related]

  • 11. The dopaminergic stabilizer ASP2314/ACR16 selectively interacts with D2(High) receptors.
    Seeman P, Tokita K, Matsumoto M, Matsuo A, Sasamata M, Miyata K.
    Synapse; 2009 Oct; 63(10):930-4. PubMed ID: 19588469
    [Abstract] [Full Text] [Related]

  • 12. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
    Pugsley TA, Davis MD, Akunne HC, MacKenzie RG, Shih YH, Damsma G, Wikstrom H, Whetzel SZ, Georgic LM, Cooke LW.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
    [Abstract] [Full Text] [Related]

  • 13. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 14. Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.
    McCormick PN, Kapur S, Reckless G, Wilson AA.
    Synapse; 2009 Nov; 63(11):998-1009. PubMed ID: 19598174
    [Abstract] [Full Text] [Related]

  • 15. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
    Audinot V, Newman-Tancredi A, Gobert A, Rivet JM, Brocco M, Lejeune F, Gluck L, Desposte I, Bervoets K, Dekeyne A, Millan MJ.
    J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
    [Abstract] [Full Text] [Related]

  • 16. New substituted 2-methylthiomethyl- and 2-methylsulphinylmethylenebenzimidazoles with D2/5-HT1A activity.
    Kostić-Rajacić S, Soskić V, Joksimović J.
    Pharmazie; 1998 Jul; 53(7):438-41. PubMed ID: 9699220
    [Abstract] [Full Text] [Related]

  • 17. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
    Seeman P, Tallerico T, Ko F.
    Synapse; 2003 Sep 15; 49(4):209-15. PubMed ID: 12827639
    [Abstract] [Full Text] [Related]

  • 18. Modification of the behavioral effects of the selective dopamine D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine by dopamine antagonists in monkeys.
    Rosenzweig-Lipson S, Bergman J.
    J Pharmacol Exp Ther; 1993 Jun 15; 265(3):1039-46. PubMed ID: 8099614
    [Abstract] [Full Text] [Related]

  • 19. Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO.
    Seeman P, McCormick PN, Kapur S.
    Synapse; 2007 May 15; 61(5):263-7. PubMed ID: 17318886
    [Abstract] [Full Text] [Related]

  • 20. Expression and pharmacological characterization of the human D3 dopamine receptor.
    Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, Knowles MR, McAllister G.
    J Pharmacol Exp Ther; 1994 Jan 15; 268(1):417-26. PubMed ID: 8301582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.